insights_auto
Why is SRPT down 2,30%?
Dive Deeperchevron_right
SRPT:NASDAQ
Sarepta Therapeutics Inc
17,44 $
arrow_downward
-2,30%(-0,41) 1D
17,45 $
arrow_upward
+0,06% (+0,010)bedtimeAfter hours
Closed: 12 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SRPT...
Open
17,88 $
High
18,14 $
Low
17,30 $
Mkt. cap
1,84 մլրդ
Avg. vol.
2,93 մլն
Volume
3,28 մլն
52-wk high
24,68 $
52-wk low
14,69 $
EPS
-1,66 $
Beta
0,38
Shares outstanding
105,63 մլն
No. of employees
835
Open
17,88 $
High
18,14 $
Low
17,30 $
Mkt. cap
1,84 մլրդ
Avg. vol.
2,93 մլն
Volume
3,28 մլն
52-wk high
24,68 $
52-wk low
14,69 $
EPS
-1,66 $
Beta
0,38
Shares outstanding
105,63 մլն
No. of employees
835
News stories
From web sources and news partners
Profile
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs. Wikipedia
About Sarepta Therapeutics Inc